BioCardia
BCDA
BCDA
25 hedge funds and large institutions have $4.87M invested in BioCardia in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.26% more ownership
Funds ownership: 0.61% → 0.87% (+0.26%)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
Holders
25
Holding in Top 10
–
Calls
$597K
Puts
$297K
Top Buyers
| 1 | +$1.24M | |
| 2 | +$306K | |
| 3 | +$24.2K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$12.7K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.15K |
Top Sellers
| 1 | -$53K | |
| 2 | -$51K | |
| 3 | -$20.8K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$10.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.38K |